acrolein has been researched along with Glioblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, KT; Chen, PY; Cheng, HW; Huang, CY; Hwang, TL; Lin, YJ; Tong, ZJ; Tsai, HC; Wang, HT; Wei, KC | 1 |
| Chang, JH; Jeong, H; Kang, SG; Kim, HS; Kim, NH; Lee, JE; Park, J; Shim, JK; Yook, JI | 1 |
| Dixit, D; Ghosh, S; Koul, N; Sen, E; Sharma, V | 1 |
3 other study(ies) available for acrolein and Glioblastoma
| Article | Year |
|---|---|
Acrolein produced by glioma cells under hypoxia inhibits neutrophil AKT activity and suppresses anti-tumoral activities.
Topics: Acrolein; Anti-Inflammatory Agents; Glioblastoma; Humans; Neutrophils; Proto-Oncogene Proteins c-akt; Tumor Microenvironment | 2023 |
Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
Topics: Acrolein; Adenosine Triphosphate; Animals; Antineoplastic Agents; Benzoates; Cell Line, Tumor; Cell Survival; Cinnamates; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplastic Stem Cells; Temozolomide; Tissue Scaffolds | 2019 |
Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells.
Topics: Acrolein; Apoptosis; Blotting, Western; Brain Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclohexanols; Glioblastoma; Humans; Proto-Oncogene Proteins c-akt; Signal Transduction; Telomerase; TOR Serine-Threonine Kinases | 2010 |